Get started
Author

Omobonike Oloruntoba

Observed names: Omobonike O Oloruntoba, Omobonike O. Oloruntoba, Omobonike Oloruntoba Sanders, Omobonike Oloruntoba-Sanders
Institution: Duke University
ORCID: 0000-0003-0669-1327
Observed ORCID: 0000-0003-0669-1327
OpenAlex ID: A5012766309
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma
2019 · Amit G. Singal, Nicole E. Rich, et al. · Gastroenterology · 198
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
2019 · Amit G. Singal, Nicole E. Rich, et al. · Gastroenterology · 169
Gender-based disparities in access to and outcomes of liver transplantation
2015 · Omobonike O Oloruntoba · World Journal of Hepatology · 55
PDF
Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation
2016 · Julius M. Wilder, Omobonike O. Oloruntoba, et al. · Liver Transplantation · 54
Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features
2020 · Hanyu Jiang, Bin Song, et al. · European Radiology · 26
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma
2019 · Nicole E. Rich, Ju Dong Yang, et al. · Clinical Gastroenterology and Hepatology · 17
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma
2024 · Neehar D. Parikh, Patricia Jones, et al. · Clinical Gastroenterology and Hepatology · 9
PDF
“Too Female” for Liver Transplantation
2018 · Omobonike O. Oloruntoba, Cynthia A. Moylan · Hepatology · 3
Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013
2016 · Julie Lynch, Scott L. DuVall, et al. · Military Medicine · 3
Predictors of hepatocellular carcinoma in LR-M category lesions, a multi-institutional analysis
2025 · Marybeth Nedrud, Tanya Wolfson, et al. · Abdominal Radiology · 2
More Than Meets the Eye?
2021 · Ying Claire Dorsey, Omobonike Oloruntoba, et al. · Clinical Liver Disease · 2
PDF
Integrating daclatasvir into hepatitis c therapy
2016 · Omobonike Oloruntoba, Andrew J. Muir · Clinical Liver Disease · 2
PDF
Evaluation and management of post-transplant infections for the hepatologist
2023 · Omobonike Oloruntoba-Sanders, Sajal D. Tanna · Clinical Liver Disease · 1
PDF
The needle in the haystack: deciphering diagnostic data in a case of acute on chronic liver failure
2023 · Michael G. Noujaim, Omobonike O. Oloruntoba, et al. · Clinical Liver Disease · 1
PDF
Clinical Progress Note: Intravenous Human Albumin in Patients With Cirrhosis
2021 · Suchita Shah Sata, Omobonike Oloruntoba Sanders, et al. · Journal of Hospital Medicine · 1
Locoregional therapy for colorectal liver metastases awaiting transplantation: Balancing tumor control with liver toxicity
2024 · Omobonike O. Oloruntoba, Andrew S. Barbas · Liver Transplantation
Direct-acting antiviral therapy significantly reduces early HCC recurrence: A multicenter u.s. cohort study.
2018 · Anjna Singal, N. Mehta, et al.
Hepatocellular Carcinoma Risk After Hepatitis C Cure
2017 · Omobonike O. Oloruntoba, Andrew J. Muir · Current treatment options in infectious diseases/Current treatment options in infectious disease
Works count: 18
Citation count: 543
H-index: 7
I10-index: 6
Year
Topic
Type